Article
Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
PloS one - 1 Jan 2014
Delacour Herve, Lushchekina Sofya, Mabboux Isabelle, Bousquet Aurore, Ceppa Franck, Schopfer Lawrence M, Lockridge Oksana, Masson Patrick
Abstract excerpt
Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene. Here, we report a case of prolonged neuromuscular block after administration of suxamethonium leading to the discovery of a novel BCHE variant (c.695T>A, p.Val204Asp). Inhibition studies, kinetic analysis and molecular dynamics were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
